Freenome has announced a strategic agreement with Roche aimed at commercialising its cancer screening technology outside the US.

There is an ongoing demand from original equipment manufacturers’ (OEMs) for their contract manufacturing partners to be vertically integrated, a manufacturer primarily involved in the diagnostics ...

Current results indicate that KOA symptoms improved over one year and that symptoms are relieved for up to three years.

Distalmotion has closed a Series G funding round totalling $150m to expedite the expansion of its soft tissue robotic surgery system, DEXTER, in the US.

Medtronic has raised its fiscal year 2026 (FY26) profit outlook to between $5.62 and $5.66 per share after the company achieved its strongest cardiovascular portfolio revenue growth in over a decade ...

Pulsed field ablation (PFA) has experienced a meteoric rise in popularity within the electrophysiology market.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for the expanded use of Onward Medical’s ARC-EX System.

Siemens has announced plans to ‘deconsolidate’ its remaining stake in Siemens Healthineers by transferring 30% of shares to Simens shareholders. The company, whose stake had stood at 67%, will hand ...

Zimmer Biomet has received 510(k) clearance from the US Food and Drug Administration (FDA) for ROSA Knee with OptimiZe technology.

Professionals involved within the UK’s National Health Service (NHS) have revealed how they think about innovation in the NHS and what considerations are critical in making technology deployment ...

Biogen has completed the acquisition of Alcyone Therapeutics, for $85m upfront payment, to boost central nervous system (CNS) drug delivery.

The market is projected to expand at a compound annual growth rate of 6% from 2024 to 2034. Growing clinical evidence is beginning draw attention to the minimally invasive neurosurgical devices market ...